Differential Hepatitis B Surface Antigen Glycan Isomer Kinetics Between Tenofovir Alafenamide and Entecavir: Hepatocellular Carcinoma Risk Stratification in Hepatitis B e Antigen‐Positive Patients

Journal of Viral Hepatitis · Published 2026-07-29 · DOI 10.1111/jvh.70218

Free full text

Authors (12)

Yuji Kita, Ayato Murata, Hiroki Nago, Masahiro Yamaguchi, Yoko Kato, Rihwa Om, Yuichro Terai, Yuji Ikeda, Sho Sato, Shunsuke Sato, Yuji Shimada, Takuya Genda

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Kita, Y., Murata, A., Nago, H., et al. (2026). Differential Hepatitis B Surface Antigen Glycan Isomer Kinetics Between Tenofovir Alafenamide and Entecavir: Hepatocellular Carcinoma Risk Stratification in Hepatitis B e Antigen‐Positive Patients. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70218

Related articles